Skip to content

Efficacy of Scleral Contact Lenses for Daily Wear for Regular and Irregular Refractive Errors Compared to Habitually Worn Scleral Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02643095
Enrollment
22
Registered
2015-12-30
Start date
2016-01-26
Completion date
2016-08-31
Last updated
2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleral Lens Wearers

Brief summary

This study will be done with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It will be fit by the investigators and will be assessed and at one week and 1 month.

Interventions

DEVICEscleral contact lens

Scleral contact lens

Sponsors

Jennifer Fogt
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Subjects may be male or female, of any race, and at least 18 years old at the time of the pre-treatment examination. 2. Subjects must habitually wear scleral contact lenses for an average wearing time of 6 hours per day. 3. The prospective eye(s) must have refractive hyperopia or myopia from +20.00 to -20.00 diopters sphere (spectacle plane), with up to -10.00 diopters of refractive astigmatism (spectacle plane), as determined by manifest refraction (phoropter or trial frame with a 12.5 mm vertex distance). 4. Subjects must have best spectacle corrected visual acuity of at least 0.5 logMAR in each eye. 5. Subjects must be willing and capable to return for all scheduled follow-up visits for a period of at least 3 months (minimum of 1 month from initial dispensing).

Exclusion criteria

1. Female subjects who are pregnant, breast-feeding or intend to become pregnant over the course of the study. 2. Subjects with a history of any of the following medical conditions: collagen vascular disease, autoimmune disease, immunodeficiency diseases, ocular herpes zoster or simplex, endocrine disorders (including, but not limited to active thyroid disorders and diabetes), lupus, and rheumatoid arthritis. Note: The presence of diabetes (either type 1 or 2), regardless of disease duration, severity or control, will specifically exclude subjects from eligibility. 3. Subjects with active ophthalmic disease or abnormality including glaucoma, chorioretinitis, central retinal artery or vein occlusion, intraocular or ocular infection. 4. Subjects who are participating in any other clinical trial (FDA or other)

Design outcomes

Primary

MeasureTime frameDescription
The Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study Lenses1 month after lens is dispensedNumber of Participants with Overall Satisfaction and Desire to Continue Wearing the Study Lenses

Participant flow

Participants by arm

ArmCount
Lens Fitting/Evaluation
This study was conducted with subjects who already habitually wear scleral contact lenses. The study lens is made with a material that is already widely available and has a new design. It was fit by the investigators and assessed and at one week and 1 month. scleral contact lens: Scleral contact lens
22
Total22

Baseline characteristics

CharacteristicLens Fitting/Evaluation
Age, Customized
Age 18 or older
22 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 21
other
Total, other adverse events
1 / 21
serious
Total, serious adverse events
0 / 21

Outcome results

Primary

The Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study Lenses

Number of Participants with Overall Satisfaction and Desire to Continue Wearing the Study Lenses

Time frame: 1 month after lens is dispensed

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Lens Fitting/EvaluationThe Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study LensesPreferred test lenses to habitual lenses15 Participants
Lens Fitting/EvaluationThe Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study LensesPreferred habitual lenses to test lenses2 Participants
Lens Fitting/EvaluationThe Primary Endpoint of the Study is the Overall Satisfaction and Desire to Continue Wearing the Study LensesNo preference4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026